Jose Oberholzer, MD
Jose Oberholzer, MD, Zurich, Switzerland
Dr. Oberholzer holds the position of Ordinarius and Chair in the Department of Surgery and Transplantation, as well as Chief of the Section of HPB and Transplant Surgery at the University Hospital of Zurich since June 1, 2023. He has extensive experience in clinical and experimental islet transplantation, abdominal organ transplantation, as well as advanced hepatobiliary and pancreatic surgery. He also serves as an Adjunct Professor of Surgery and Medicine at the University of Illinois Hospital & Health Sciences System since March 2017. He is founding member of the Clinical Robotic Surgical Association, and pioneered robotic surgery since 2003.
He has been actively involved in medical innovation and collaboration. He is the Founder and Coordinator of the Chicago Diabetes Project, an international initiative focused on a functional cure for diabetes since 2004. He is a Founding Scientist of Sigilon Therapeutics, an MIT start-up (www.sigilon.com), and the Founder and President of CellTrans Inc, a UIC start-up (Celltransinc.com).